Wave Life Sciences WVE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's investing cash flow?
- Wave Life Sciences (WVE) reported investing cash flow of -$438K in Q1 2026.
- How has Wave Life Sciences's investing cash flow changed year-over-year?
- Wave Life Sciences's investing cash flow decreased by 165.5% year-over-year, from -$165K to -$438K.
- What is the long-term trend for Wave Life Sciences's investing cash flow?
- Over 3 years (2021 to 2025), Wave Life Sciences's investing cash flow has grown at a 8.7% compound annual growth rate (CAGR), from -$560K to -$719K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.